These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 20837338

  • 1. Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.
    Sebrango A, Vicuña I, de Laiglesia A, Millán I, Bautista G, Martín-Donaire T, Regidor C, Cabrera R, Fernandez MN.
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):259-74. PubMed ID: 20837338
    [Abstract] [Full Text] [Related]

  • 2. Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors.
    Fernández MN.
    Br J Haematol; 2009 Oct; 147(2):161-76. PubMed ID: 19796265
    [Abstract] [Full Text] [Related]

  • 3. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
    Magro E, Regidor C, Cabrera R, Sanjuán I, Forès R, Garcia-Marco JA, Ruiz E, Gil S, Bautista G, Millán I, Madrigal A, Fernandez MN.
    Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
    [Abstract] [Full Text] [Related]

  • 4. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
    Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.
    N Engl J Med; 2004 Nov 25; 351(22):2265-75. PubMed ID: 15564543
    [Abstract] [Full Text] [Related]

  • 5. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
    Martín-Donaire T, Rico M, Bautista G, Gonzalo-Daganzo R, Regidor C, Ojeda E, Sanjuán I, Forés R, Ruiz E, Krsnik I, Navarro B, Gil S, Magro E, Millán I, Sánchez R, Pérez-Sanz N, Panadero N, García-Marco JA, Cabrera R, Fernández MN.
    Bone Marrow Transplant; 2009 Aug 25; 44(4):213-25. PubMed ID: 19252533
    [Abstract] [Full Text] [Related]

  • 6. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Rico MA, Bautista G, Krsnik I, Forés R, Ojeda E, Sanjuán I, García-Marco JA, Navarro B, Gil S, Sánchez R, Panadero N, Gutiérrez Y, García-Berciano M, Pérez N, Millán I, Cabrera R, Fernández MN.
    Cytotherapy; 2009 Aug 25; 11(3):278-88. PubMed ID: 19308773
    [Abstract] [Full Text] [Related]

  • 7. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A, Ciceri F, Gluckman E, Labopin M, Rocha V, Eurocord and Acute Leukemia Working Party of the European Blood and Marrow Transplant Group.
    Best Pract Res Clin Haematol; 2010 Jun 25; 23(2):207-16. PubMed ID: 20837332
    [Abstract] [Full Text] [Related]

  • 8. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F, Reisner Y, Martelli MF.
    Blood Cells Mol Dis; 2004 Jun 25; 33(3):294-302. PubMed ID: 15528148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 25; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 12. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 Feb 25; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 13. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
    Atsuta Y, Morishima Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kobayashi N, Fukuda T, Azuma H, Takanashi M, Mori T, Tsuchida M, Kawase T, Kawa K, Kodera Y, Kato S, Japan Marrow Donor Program and Japan Cord Blood Bank Network.
    Biol Blood Marrow Transplant; 2012 May 25; 18(5):780-7. PubMed ID: 22008851
    [Abstract] [Full Text] [Related]

  • 14. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F, Diyachenko G, Zabelina T, Panse J, Wolschke C, Eiermann T, Binder T, Fehse B, Erttmann R, Kabisch H, Bacher U, Kröger N, Zander AR.
    Exp Hematol; 2008 Aug 25; 36(8):1047-54. PubMed ID: 18456390
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
    González-Vicent M, Molina B, Andión M, Sevilla J, Ramirez M, Pérez A, Díaz MA.
    Eur J Haematol; 2011 Jul 25; 87(1):46-53. PubMed ID: 21692851
    [Abstract] [Full Text] [Related]

  • 16. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Jul 25; 216(6):356-63. PubMed ID: 15565551
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA, Hewlett B, Ranalli M, Seshadri R, Duerst R, Kletzel M.
    Bone Marrow Transplant; 2004 Nov 25; 34(10):901-7. PubMed ID: 15361908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.
    Shaw BE, Potter MN, Mayor NP, Pay AL, Smith C, Goldman JM, Prentice HG, Marsh SG, Madrigal JA.
    Bone Marrow Transplant; 2003 Jun 25; 31(11):1001-8. PubMed ID: 12774051
    [Abstract] [Full Text] [Related]

  • 20. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
    Willemze R, Ruggeri A, Purtill D, Rodrigues CA, Gluckman E, Rocha V, Eurocord and of the European Group of Blood and Marrow Transplantation.
    Best Pract Res Clin Haematol; 2010 Jun 25; 23(2):283-90. PubMed ID: 20837340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.